Procizumab
Procizumab (AK-1967) is a humanized IgG1 antibody that targets dipeptidyl peptidase 3 (DPP3) . Procizumab has the potential for the study of sepsis. The isotype control for Procizumab can refer to Human IgG1 kappa, Isotype Control (HY-P99001) [1].
Product Specifications
Product Name Alternative
AK-1967
UNSPSC
12352203
Target
Dipeptidyl Peptidase
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
[Procizumab]
References & Citations
[1]Garcia B, et al. Inhibition of circulating dipeptidyl-peptidase 3 by procizumab in experimental septic shock reduces catecholamine exposure and myocardial injury. Intensive Care Med Exp. 2024 Jun 7;12 (1) :53.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
TL302867V 500 µL Each
Netrin 4 (NTN4) Human shRNA Lentiviral Particle (Locus ID 59277)
Ask
View Details MBS1223893-01 0.02 mg (E-Coli)
Recombinant Mycobacterium sp. ATP synthase epsilon chain (atpC)
Ask
View Details 
MBS1223893-02 0.1 mg (E-Coli)
Recombinant Mycobacterium sp. ATP synthase epsilon chain (atpC)
Ask
View Details MBS1223893-03 0.02 mg (Yeast)
Recombinant Mycobacterium sp. ATP synthase epsilon chain (atpC)
Ask
View Details MBS1223893-04 0.1 mg (Yeast)
Recombinant Mycobacterium sp. ATP synthase epsilon chain (atpC)
Ask
View Details 
MBS1223893-05 0.02 mg (Baculovirus)
Recombinant Mycobacterium sp. ATP synthase epsilon chain (atpC)
Ask
View Details